The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...
Fabry disease (FD) is a genetic disease, with X-chromosome linked inheritance, due to variants in the GLA gene that encodes the α-galactosidase A (α-GAL) enzyme. The purpose of the present study was to create a consensus aiming to standardize the recommendations regarding the renal involvement of FD wi...
This guideline covers care and treatment for people with, or at risk of, chronic kidney disease
(CKD). It aims to prevent or delay the progression, and reduce the risk of complications and
cardiovascular disease. It also covers managing anaemia and hyperphosphataemia associated with
CKD.
NICE has produce...
Cheung, Alfred;
Chag, Tara;
Cushman, William;
Furth, Susan;
Hou, Fan;
Ix, Joachim;
Knoll, Gregory;
Muntner, Paul;
Pecoits-Filho, Roberto;
Sarnak, Mark;
Tobe, Sheldon;
Tomson, Charles;
Lytvyn, Lyubov;
Craig, Jonathan;
Tunnicliffe, David;
Howell, Martin;
Tnoelli, Marcelo;
Cheung, Michael;
Earley, Amy;
Mann, Johannes.
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease for patients not receiving dialysis represents an update to the KDIGO 2012 guideline on this topic. Development of this guideline update followed a rigorou...
The purpose of this guideline is to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources....
Lok, Charmaine E;
Huber, Thomas S;
Lee, Timmy;
Shenoy, Surendra;
Yevzlin, Alexander S;
Abreo, Kenneth;
Allon, Michael;
Asif, Arif;
Astor, Brad C;
Glickman, Marc H;
Graham, Janet;
Moist, Louise M;
Rajan, Dheeraj K;
Roberts, Cynthia;
Vachharajani, Tushar J;
Valentini, Rudolph P.
The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidencebased guidelines for hemodialysis vascular access since 1996. Since the last update in 2006, there has been a
great accumulation of new evidence and sophistication in the guidelines process. The 201...
This guideline covers renal replacement therapy (dialysis and transplantation) and conservative management for people with chronic kidney disease stages 4 and 5....
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice Guideline for Hemodialysis Adequacy is intended to...
This guideline covers diagnosing, assessing, managing and monitoring anaemia in people with chronic kidney disease. It aims to improve care for people with chronic kidney disease by specifying how to assess when their anaemia needs treating, and by making detailed recommendations on treatment with erythr...
This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....